CROs in drug development: "We use our expertise to speed up the process

Consultancy firms have become an increasingly important part of drug development. “It’s a trend and a business model that works, and we see no indication that i...

New drug alert in the US: Rise in overdoses linked to the use of drugs for animals

A combination of the synthetic drugs fentanyl and xylazine, an animal tranquilizer, has been labelled a “growing threat” by the White House due to its role in t...

“Conducting research at universities is becoming more and more like working at a research hotel”

The government wants Swedish research to focus on excellence and innovation, but can the two be combined? Life Science Sweden talks to Anna Falk, a professor at...

“Life science is important on a personal level”

From the High Coast to the Government Offices. Jeanette Edblad is a native of Ångermanland, and since September last year, she has been Head and Coordinator of ...

40,000 DNA extractions daily

It's great when things run quickly: 20 minutes per extraction process and a new plate every 2.5 minutes – the Dutch company Synchron Lab Automation, in cooperat...

Marie Gårdmark: Potential step change – EU regulators get to play with data

to the outcome of the pilot to hopefully then understand if “in house” analyses actually will add value.

Amorphous materials take centre stage when Orexo develops new formulations

Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...

Column: "Are we already living in the new normal?"

2020 felt like the year that we were building the house around us whilst moving into it at the same time.

Integrated solutions for liquid handling

Greater efficiency for manufacturers in laboratory automation and many other industries

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...

Hon ska marknadsföra stamceller

Entreprenören och bloggaren Isabella Löwengrip ska öka stamcellsbolaget Nextcell pharmas digitala närvaro.

Collaboration in laboratory automation

The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

Forskare har hittat sätt att rensa kroppen på triglycerider

Två amerikanska forskare har hittat ett sätt att i laboratoriet framställa ett mänskligt protein, kallad APOA 5, som normalt sätt produceras i levern.

“Register och journalsystem borde vara samma sak”

Sverige ett framgångsrikt land inom medicinsk forskning, men hur ser det ut i dag och hur blir vi världsbäst?

Fest för pengaregn över svenska bolag

Barbro Ehnbom är en i svensk forskning och life science-industri ovanligt glamorös karaktär. Hennes möte Salss är också ett ovanligt event. Investerare och ledn...

Medivir outsourcar substansbibliotek

Läkemedelsbolaget Medivir har outsourcat hela sitt substansbibliotek till det brittiska bolaget BioAscent Discovery.

Big pharma flyttar till KI

Det globala life science-bolaget Bayer flyttar in på KI:s campus. Flytten symboliserar kraften i samverkan säger företagets vd.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

”Riskerar att bli kännbart för många företag”

Vikande lönsamhet när kemiindustrin förbereder för hård Brexit. IKEM:s chefsekonom Carl Eckerdal varnar.

Quotient Sciences Limited

Cellterapier, nanomunkar och AI

Maskininlärning, 3D-printing på nanonivå och DNA för datalagring – det var några av de ämnen som togs upp på mötet Bioscience under gårdagen.

Årets Möjliggörare: Magnus Björsne

Magnus Björsne är chef för AstraZenecas BioVentureHub samt hjärnan bakom en ny arbetsmodell som förhoppningsvis ska ge fler tidiga bolag i Sverige.

Säkerhet senaste outsourcing-trenden

Allt fler big pharma-företag lägger ut sin farmakovigilansverksamhet på andra aktörer.